Innovate, a clinical stage biotechnology company, is focused on developing novel medicines for autoimmune/ inflammatory disease. Our pipeline includes drug candidates for celiac disease, an unmet need, and ulcerative colitis. Innovate is led by a strong management team with extensive drug development experience and a history of bringing novel therapeutics to market. All global rights to the products, which are backed by more than 150 patents worldwide, are owned by the company.
Innovate is currently developing three clinical stage assets: